VYNE THERAPEUTICS INC
NASDAQ: VYNE (VYNE Therapeutics Inc.)
Last update: 19 hours ago0.509
-0.41 (-44.88%)
| Previous Close | 0.923 |
| Open | 0.487 |
| Volume | 2,761,649 |
| Avg. Volume (3M) | 722,472 |
| Market Cap | 339,859 |
| Price / Sales | 88.36 |
| Price / Book | 1.27 |
| 52 Weeks Range | |
| TTM Dividend Yield | 79.06% |
| Operating Margin (TTM) | -4,552.97% |
| Diluted EPS (TTM) | -0.980 |
| Quarterly Revenue Growth (YOY) | 106.10% |
| Total Debt/Equity (MRQ) | 0.14% |
| Current Ratio (MRQ) | 4.47 |
| Operating Cash Flow (TTM) | -37.45 M |
| Levered Free Cash Flow (TTM) | -20.39 M |
| Return on Assets (TTM) | -38.37% |
| Return on Equity (TTM) | -66.15% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | VYNE Therapeutics Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 0.00 |
|
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 8.34% |
| % Held by Institutions | 47.62% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Lynx1 Capital Management Lp | 31 Mar 2026 | 1,628,700 |
| T3 Companies, Llc | 31 Mar 2026 | 945,000 |
| Kvp Capital Advisors, Lp | 31 Mar 2026 | 500,551 |
No data within this time range.
| TTM Dividend Yield | 79.06% |
| Expected Next Dividend Payment | Jul 2027 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 24 Jul 2026 | 10 Jul 2026 | 23 Jul 2026 | 0.40242 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2026 | 0.402 | 1 | 79.06 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |